Skip to main content
. 2015 Jul 23;10(4):1970–1978. doi: 10.3892/ol.2015.3524

Figure 3.

Figure 3.

Correlation of progression-free survival with HIF-1α, CA-IX, GLUT-1 and VEGF expression levels in cervical cancer patients treated with radiotherapy or chemo-radiotherapy following radical hysterectomy. Expression of HIF-1α, CA-IX, GLUT-1 and VEGF was immunohistochemically analyzed in 35 patients with cervical cancer. Progression-free survival time over 110 months was analyzed using the Kaplan-Meier method and a log-rank test. HIF-1α, hypoxia-inducible factor-1α; CA-IX, carbonic anhydrase-IX; GLUT-1, glucose transporter-1 glucose transporter-1; VEGF, vascular endothelial growth factor; PFS, progression-free survival.